CM
IDYA icon

Caption Management’s IDEAYA Biosciences IDYA Stock Holding History

Caption Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.6M Buy
977,800
+527,800
+117% +$17.7M 0.19% 111
2025
Q4 		$15.6M Buy
+450,000
New +$14.3M 0.11% 230
2025
Q2 		– Sell
-27,100
Closed -$444K – 1666
2025
Q1 		$444K Buy
+27,100
New +$577K ﹤0.01% 1125

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Caption Management's IDYA Position: Q1 2026 in Review

Caption Management sold out of IDEAYA Biosciences (IDYA) in Q1 2026, closing a stake of 57,167 shares — an estimated $1.92M sold.

Caption Management first reported a position in IDYA in Q2 2025 and held it in 3 quarters. The position peaked at $1.98M in Q4 2025. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Caption Management reported no remaining IDEAYA Biosciences position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 57,167 IDEAYA Biosciences shares in Q1 2026, an estimated $1.92M.
  • Caption Management first reported a position in IDEAYA Biosciences in Q2 2025 and held it in 3 quarters.
  • Caption Management's IDEAYA Biosciences position peaked at $1.98M in Q4 2025.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.